Chest · 2024
Treatment of Acute Circulatory Failure Based on Carbon Dioxide-Oxygen (CO2-O2) Derived Indices: The Lactel Randomized Multicenter Study.
СтатьяМногоцентровое исследованиеРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Guinot Pierre-Grégoire, Evezard Corentin, Nguyen Maxime, Pili-Floury Sebastien, Berthoud Vivien, Besch Guillaume, Bouhemad Belaid, Lactel Study Group
Аннотация
BACKGROUND: Acute circulatory failure is critical in patients in the ICU. Indices derived from oxygen and CO2 metabolism (CO2-O2-derived indices) including the central venous-to-arterial CO2 difference and central venous-to-arterial CO2 difference/arteriovenous oxygen content ratio are markers for global metabolic demand and tissue hypoxia.
RESEARCH QUESTION: Does a resuscitation strategy using CO2-O2-derived indices improve tissular hypoperfusion compared with standard care?
STUDY DESIGN AND METHODS: We conducted a randomized, prospective, multicenter, single-anonymized study in 3 ICUs. Patients aged ≥ 18 years with acute circulatory failure and arterial blood lactate levels ≥ 3 mM were included. Patients were randomized to receive either a CO2-O2-derived algorithm-based treatment or standard clinical practice. The primary outcome was lactate clearance > 10% within 2 hours. Secondary outcomes included Sepsis-Related Organ Failure Assessment score and mortality.
RESULTS: Of the 179 patients enrolled (90 control patients and 89 treatment patients), there was no significant difference in achieving a lactate clearance > 10% at 2 hours between the control (50%) and interventional groups (43.8%) (P = .497). At t2 hours, the median change in lactate levels in the control group was -10.53% (-29.27 to 5.68), whereas in the interventional group, it was -2.70% (-22.58 to 19.1; P = .096). Secondary outcomes did not differ between groups in Sepsis-Related Organ Failure Assessment scores (6 [3 to 9] vs 7 [4 to 10]; P = .719), ICU and hospital length of stay (4.5 days [2.0 to 10.8] vs 5.0 days [2.0 to10.0]; P = .963 and 11 days [3.0 to 27.0] vs 10 days [3.0 to 21.0]; P = .493), or 28-day mortality (44.9% vs 33.3%, P = .150).
INTERPRETATION: Our results indicate that algorithm-based resuscitation using CO2-O2-derived indices did not improve lactate clearance or clinical outcomes compared with standard care. Further research is needed to identify specific patient subgroups who may benefit from this approach.
CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT05032521; URL: www.
CLINICALTRIALS: gov.
RESEARCH QUESTION: Does a resuscitation strategy using CO2-O2-derived indices improve tissular hypoperfusion compared with standard care?
STUDY DESIGN AND METHODS: We conducted a randomized, prospective, multicenter, single-anonymized study in 3 ICUs. Patients aged ≥ 18 years with acute circulatory failure and arterial blood lactate levels ≥ 3 mM were included. Patients were randomized to receive either a CO2-O2-derived algorithm-based treatment or standard clinical practice. The primary outcome was lactate clearance > 10% within 2 hours. Secondary outcomes included Sepsis-Related Organ Failure Assessment score and mortality.
RESULTS: Of the 179 patients enrolled (90 control patients and 89 treatment patients), there was no significant difference in achieving a lactate clearance > 10% at 2 hours between the control (50%) and interventional groups (43.8%) (P = .497). At t2 hours, the median change in lactate levels in the control group was -10.53% (-29.27 to 5.68), whereas in the interventional group, it was -2.70% (-22.58 to 19.1; P = .096). Secondary outcomes did not differ between groups in Sepsis-Related Organ Failure Assessment scores (6 [3 to 9] vs 7 [4 to 10]; P = .719), ICU and hospital length of stay (4.5 days [2.0 to 10.8] vs 5.0 days [2.0 to10.0]; P = .963 and 11 days [3.0 to 27.0] vs 10 days [3.0 to 21.0]; P = .493), or 28-day mortality (44.9% vs 33.3%, P = .150).
INTERPRETATION: Our results indicate that algorithm-based resuscitation using CO2-O2-derived indices did not improve lactate clearance or clinical outcomes compared with standard care. Further research is needed to identify specific patient subgroups who may benefit from this approach.
CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT05032521; URL: www.
CLINICALTRIALS: gov.